There are several different treatments available for the management of lipoedema such as compression therapy, exercise and massage. There is limited evidence on the efficacy of liposuction for the treatment of lipoedema, and it is not routinely available on the National Health Service.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2016-03-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-03-15T11:19:17.94Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-03-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Lipoedema"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will implement a treatment pathway for people who suffer from lipoedema to allow such people to receive liposuction on the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "30284"} , {"_about" : "http://data.parliament.uk/resources/433830", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/433830/answer", "answerText" : {"_value" : "
Policy responsibility for the Vaccine Damage Payment Scheme transferred to the Department of Health from the Department for Work and Pensions (DWP) in May 2014 although DWP continues to administer this scheme. The scheme was last revised in 2007 and no assessment of effectiveness has been made since that date.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-12-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-12-07T13:53:40.54Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-12-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Vaccine Damage Payment Scheme"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the Vaccine Damage Payment scheme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"}
}
, "tablingMemberConstituency" : {"_value" : "York Outer"}
, "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"}
], "uin" : "902566"}
, {"_about" : "http://data.parliament.uk/resources/422666", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/422666/answer", "answerText" : {"_value" : "
Since 2011, the Department of Health has provided our delivery partners, NHS Blood and Transplant and Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.<\/p>
The Government remains committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor. The report \u2018Destination Cure \u2013 arriving at a better future\u2019 from Anthony Nolan provides a timely contribution to this work.<\/p>
"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-10-28", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-10-28T17:09:26.3Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-10-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blood Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, if he will take further steps to support Anthony Nolan's Destination Cure campaign.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"}
}
, "tablingMemberConstituency" : {"_value" : "York Outer"}
, "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"}
], "uin" : "12658"}
, {"_about" : "http://data.parliament.uk/resources/105962", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/105962/answer", "answerText" : {"_value" : "
For National Health Service funded in-vitro fertilisation treatment, it is for clinical commissioning groups to decide with which fertility clinics to contract and agree the price payable with the service provider.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-11-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-10T17:39:40.4263078Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-11-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to reduce variation in the price of IVF cycles between clinical commissioning groups.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "212894"} , {"_about" : "http://data.parliament.uk/resources/101567", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/101567/answer", "answerText" : {"_value" : "
In addition to departure screening in affected countries, entry screening has been introduced for people travelling to the United Kingdom from Ebola infected areas. This also provides them with clear advice about immediate actions should they develop any relevant symptoms.<\/p>
<\/p>
<\/p>
<\/p>
There are already public health powers in place to enable the quarantining of an individual suffering from the symptoms of Ebola should they be needed.<\/p>
<\/p>
<\/p>
<\/p>
The Government keeps the threat posed to the UK by the spread of Ebola virus disease, and the measures required to tackle it, under regular review.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-11-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-05T15:23:28.1786028Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ebola"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what contingency plans the Government is making for quarantine procedures for people entering the UK from countries where the Ebola virus is present in the event of a further spread of that virus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "212378"} , {"_about" : "http://data.parliament.uk/resources/101647", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/101647/answer", "answerText" : {"_value" : "
We recognise that drinking alcohol and drug use does place significant strain on the National Health Service, but there are both ethical and practical reasons not to seek payment from patients. The founding principle of the NHS is that services are free of charge, available to all on the basis of need, not ability to pay. It is funded accordingly, from general taxation.<\/p>
<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-11-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-05T15:40:41.9778304Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will make an assessment of the potential merits of charging for NHS services required because of injuries caused by alcohol or drug misuse.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "212524"} , {"_about" : "http://data.parliament.uk/resources/57963", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/57963/answer", "answerText" : {"_value" : "
Currently donated lungs are allocated to the designated cardiothoracic transplant centres on a zonal basis. However, the Cardiothoracic Organs Advisory Group (CTAG) have recently reviewed the allocation policy and have recommended that the size of the allocation zones be adjusted to help ensure equity of access. NHS Blood and Transplant (NHSBT) have therefore confirmed that for cardiothoracic organs, the zones will be reviewed in August 2014 to coincide with changes in liver allocation zones and from August 2015, heart and lung zones will be disaggregated and the zones reviewed separately.<\/p>
<\/p>
CTAG have also recommended that NHSBT reviews the consequences of introducing two levels of priority for listing for lung transplants - urgent and routine, and suggest a national allocation scheme for urgent listed patients, and zonal allocation for routine listed patients.<\/p>
<\/p>
Any proposed change would need to be validated by NHSBT, who will review the criteria for urgent listing and the statistical modelling of the potential impact of such a system. NHSBT will continue to work closely with the Cystic Fibrosis Trust to improve outcomes for patients requiring lung transplants.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-06-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-06-11T15:43:54.7503328Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-06-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cystic Fibrosis"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, with reference to the Cystic Fibrosis Trust's report entitled Hope for More: Improving access to lung transplantation and care for people with cystic fibrosis, what assessment he has made of the donor lung utilisation rate for transplantation; and what measures he has identified as having the greatest potential to increase such utilisation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"} } , "tablingMemberConstituency" : {"_value" : "York Outer"} , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"} ], "uin" : "199027"} , {"_about" : "http://data.parliament.uk/resources/49470", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/49470/answer", "answerText" : {"_value" : "
The UK National Screening Committee advises Ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. It is currently reviewing the evidence for screening young people between the ages of 12 to 39 years for the major causes of sudden cardiac death. A public consultation will open shortly.<\/p>
<\/strong><\/p> NHS England is working with the Chief Coroner to discuss what the coronial system can do to help reduce sudden cardiac death in the young. As a result, the Chief Coroner has written to local Coroners asking them to make families of those who have died of the condition aware that it may be inherited, and encouraging them to contact either the British Heart Foundation, Cardiac Risk in the Young, or their general practitioner for testing and counselling.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-05-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-05-12T12:00:00.00Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-05-01", "_datatype" : "dateTime"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what recent steps he has taken to raise awareness of the conditions that can lead to young sudden cardiac death and sudden death syndrome.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"}
}
, "tablingMemberConstituency" : {"_value" : "York Outer"}
, "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"}
], "uin" : "197438"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 8, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}